Tayyeba K Ali, MD
Ophthalmology · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ali’s office at (408) 524-5900 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C150277 · Current
Licensed to practise in California · since 2017 · expires 2027-05-31 · Emory University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$27,824
Medicare paid this office $27,824 for 68 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 55 | $12,031 | $118 |
| Long return visit (40+ min) | 21 | $7,915 | $168 |
| Imaging of retina | 17 | $1,172 | $40 |
| Imaging of optic nerve | 26 | $941 | $35 |
Who their Medicare patients are
68 Original Medicare patients in 2024. Average age 77 · Women 66% · Also on Medicaid 19% · Health risk score 1.01. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 60% · Chronic kidney disease 24% · Diabetes 18% · Cancer 16%.
The office billed $100,730, Medicare allowed $36,043 and paid $27,824; for 255 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 68 | 255 | 77 | 1.01 | $100,730 | $27,824 |
| 2023 | 52 | 184 | 76 | 1.08 | $65,634 | $18,460 |
| 2022 | 55 | 186 | 79 | 1.06 | $64,971 | $19,640 |
| 2021 | 54 | 167 | 76 | 1.04 | $57,055 | $18,730 |
| 2020 | 26 | 91 | 72 | 1.00 | $27,808 | $8,722 |
| 2017 | 214 | 528 | 70 | 1.57 | $151,203 | $38,375 |
| 2016 | 287 | 924 | 69 | 1.40 | $244,024 | $67,434 |
| 2015 | 132 | 217 | 71 | 1.72 | $57,553 | $15,136 |
| 2014 | 137 | 166 | 76 | 1.56 | $44,564 | $10,762 |
| 2013 | 153 | 205 | 70 | 1.58 | $41,267 | $12,495 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 47 | $10,428 | $113 |
| Long return visit (40+ min) | 13 | $4,519 | $167 |
| Imaging of retina | 14 | $995 | $40 |
2022: 3 services
| Return visit (30+ min) | 48 | $13,170 | $114 |
| Long return visit (40+ min) | 17 | $3,338 | $167 |
| Imaging of retina | 14 | $652 | $38 |
2021: 1 service
| Return visit (30+ min) | 49 | $16,318 | $117 |
2020: 1 service
| Return visit (30+ min) | 22 | $7,505 | $106 |
2017: 11 services
| Return visit (30+ min) | 102 | $8,627 | $49 |
| Removal of cataract with insertion of prosthetic lens | 13 | $7,843 | $461 |
| Established patient complete exam of visual system | 64 | $2,872 | $44 |
| Established patient problem focused exam of visual system | 34 | $1,440 | $39 |
| New patient complete exam of visual system | 21 | $1,424 | $68 |
| New patient visit (45+ min) | 15 | $1,296 | $86 |
| Imaging of retina | 37 | $966 | $17 |
| Measurement of corneal curvature and depth of eye | 15 | $458 | $23 |
| Exam of visual field with extended testing | 20 | $337 | $16 |
| Imaging of optic nerve | 22 | $272 | $12 |
| Ct scan of cornea | 16 | $252 | $14 |
2016: 12 services
| Removal of cataract with insertion of prosthetic lens | 28 | $17,729 | $455 |
| Return visit (30+ min) | 118 | $14,811 | $55 |
| Established patient complete exam of visual system | 89 | $4,920 | $52 |
| New patient complete exam of visual system | 63 | $4,392 | $70 |
| New patient visit (45+ min) | 43 | $3,639 | $85 |
| Established patient problem focused exam of visual system | 39 | $1,652 | $38 |
| Imaging of retina | 50 | $1,478 | $21 |
| Measurement of corneal curvature and depth of eye | 34 | $1,144 | $23 |
| Exam of visual field with extended testing | 31 | $798 | $21 |
| Imaging of optic nerve | 25 | $567 | $20 |
| Ct scan of cornea | 30 | $513 | $14 |
| Ultrasound scan of cornea to determine thickness | 59 | $331 | $6 |
2015: 6 services
| Return visit (30+ min) | 22 | $1,994 | $59 |
| New patient visit (45+ min) | 15 | $1,467 | $98 |
| Imaging of retina | 43 | $1,104 | $22 |
| Established patient complete exam of visual system | 15 | $1,007 | $63 |
| Established patient problem focused exam of visual system | 13 | $458 | $35 |
| Ultrasound scan of cornea to determine thickness | 22 | $163 | $7 |
2014: 5 services
| Established patient problem focused exam of visual system | 40 | $2,023 | $43 |
| Established patient problem focused exam of visual system | 13 | $859 | $61 |
| Emergency department visit with low level of medical decision making | 14 | $589 | $42 |
| Imaging of retina | 14 | $322 | $23 |
| Short return visit | 12 | $308 | $22 |
2013: 4 services
| New patient visit (45+ min) | 28 | $2,487 | $89 |
| Return visit (30+ min) | 37 | $2,177 | $57 |
| Established patient problem focused exam of visual system | 29 | $1,603 | $45 |
| New patient complete exam of visual system | 15 | $1,113 | $74 |
Drugs they prescribed that Part D paid
$53,704
Pharmacies billed $53,704 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 382) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
267 generic and 115 brand-name prescriptions · $53,704 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Valganciclovir | 12 | $2,648 | $221 |
| Brimonidine | 31 | $2,460 | $79 |
| Prednisolone Acetate | 43 | $2,428 | $56 |
| Difluprednate | 20 | $2,264 | $113 |
| Dorzolamide-Timolol | 64 | $1,262 | $20 |
See all 11 drugs
| Valganciclovir | 12 | $2,648 | $221 |
| Brimonidine | 31 | $2,460 | $79 |
| Prednisolone Acetate | 43 | $2,428 | $56 |
| Difluprednate | 20 | $2,264 | $113 |
| Dorzolamide-Timolol | 64 | $1,262 | $20 |
| Latanoprost | 54 | $1,078 | $20 |
| Valacyclovir | 21 | $937 | $45 |
| Travoprost | 15 | $861 | $57 |
| Timolol Maleate | 42 | $407 | $10 |
| Acyclovir | 14 | $363 | $26 |
| Dorzolamide | 11 | $106 | $10 |
Year by year
| 2024 | 382 | 98 | 0% (0) | 30% | $53,704 |
| 2023 | 260 | 83 | 0% (0) | 31% | $42,695 |
| 2022 | 269 | 75 | 0% (0) | 36% | $49,675 |
| 2021 | 231 | 71 | 0% (0) | 40% | $28,649 |
| 2020 | 124 | 46 | 0% (0) | 34% | $12,020 |
| 2019 | 146 | 52 | 0% (0) | 29% | $17,229 |
| 2018 | 1,089 | 237 | 0% (0) | 36% | $82,564 |
| 2017 | 734 | 149 | 0% (0) | 41% | $60,170 |
| 2016 | 405 | 94 | 0% (0) | 44% | $30,679 |
| 2015 | 111 | 51 | 0% (0) | 50% | $11,311 |
| 2014 | 357 | 134 | 0% (0) | None | $27,624 |
| 2013 | 143 | 76 | 0% (0) | 44% | $10,666 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Difluprednate | 22 | $3,809 | $173 |
| Prednisolone Acetate | 31 | $1,701 | $55 |
| Dorzolamide-Timolol | 29 | $1,381 | $48 |
| Valacyclovir | 18 | $1,305 | $72 |
| Latanoprost | 36 | $989 | $27 |
| Timolol Maleate | 32 | $742 | $23 |
| Brimonidine | 16 | $339 | $21 |
2022: 9 drugs
| Rocklatan | 11 | $3,806 | $346 |
| Difluprednate | 17 | $3,096 | $182 |
| Brimonidine | 14 | $2,669 | $191 |
| Valacyclovir | 19 | $2,385 | $126 |
| Dorzolamide-Timolol | 30 | $1,648 | $55 |
| Latanoprost | 30 | $1,457 | $49 |
| Dorzolamide-Timolol | 11 | $1,316 | $120 |
| Prednisolone Acetate | 15 | $836 | $56 |
| Timolol Maleate | 30 | $532 | $18 |
2021: 8 drugs
| Prednisolone Acetate | 17 | $1,487 | $87 |
| Dorzolamide-Timolol | 12 | $1,436 | $120 |
| Latanoprost | 30 | $1,243 | $41 |
| Brimonidine | 16 | $1,118 | $70 |
| Valacyclovir | 11 | $1,048 | $95 |
| Dorzolamide-Timolol | 20 | $948 | $47 |
| Dorzolamide | 13 | $746 | $57 |
| Timolol Maleate | 25 | $318 | $13 |
2020: 2 drugs
| Prednisolone Acetate | 16 | $795 | $50 |
| Latanoprost | 12 | $441 | $37 |
2019: 4 drugs
| Prednisolone Acetate | 12 | $690 | $58 |
| Brimonidine | 24 | $338 | $14 |
| Timolol Maleate | 13 | $275 | $21 |
| Latanoprost | 13 | $263 | $20 |
2018: 20 drugs
| Prednisolone Acetate | 246 | $18,661 | $76 |
| Restasis | 34 | $18,093 | $532 |
| Xiidra | 20 | $11,191 | $560 |
| Durezol | 21 | $5,421 | $258 |
| Fluorometholone | 33 | $3,848 | $117 |
| Mycophenolate Mofetil | 23 | $2,358 | $103 |
| Valacyclovir | 35 | $2,005 | $57 |
| Diclofenac | 139 | $1,886 | $14 |
| Polymyxin B Sul-Trimethoprim | 123 | $1,447 | $12 |
| Prednisone | 57 | $1,235 | $22 |
| Ofloxacin | 57 | $1,197 | $21 |
| Brimonidine | 54 | $905 | $17 |
| Latanoprost | 43 | $830 | $19 |
| Pilocarpine | 11 | $817 | $74 |
| Famciclovir | 12 | $728 | $61 |
| Doxycycline Monohydrate | 13 | $466 | $36 |
| Dorzolamide-Timolol | 27 | $458 | $17 |
| Ketorolac Tromethamine | 25 | $457 | $18 |
| Timolol Maleate | 23 | $374 | $16 |
| Neomycin-Polymyxin-Dexameth | 12 | $214 | $18 |
2017: 17 drugs
| Restasis | 24 | $10,407 | $434 |
| Prednisolone Acetate | 128 | $6,310 | $49 |
| Xiidra | 11 | $5,299 | $482 |
| Travatan Z | 21 | $5,254 | $250 |
| Durezol | 26 | $4,486 | $173 |
| Lotemax | 12 | $2,332 | $194 |
| Vigamox | 12 | $1,894 | $158 |
| Dorzolamide-Timolol | 59 | $1,282 | $22 |
| Fluorometholone | 15 | $1,107 | $74 |
| Latanoprost | 92 | $1,078 | $12 |
| Valacyclovir | 22 | $1,036 | $47 |
| Brimonidine | 67 | $1,024 | $15 |
| Ketorolac Tromethamine | 25 | $738 | $30 |
| Methotrexate | 12 | $499 | $42 |
| Prednisone | 42 | $478 | $11 |
| Timolol Maleate | 24 | $170 | $7 |
| Gabapentin | 12 | $95 | $8 |
2016: 15 drugs
| Restasis | 16 | $6,508 | $407 |
| Travatan Z | 21 | $4,548 | $217 |
| Prednisolone Acetate | 66 | $2,789 | $42 |
| Durezol | 14 | $2,158 | $154 |
| Lotemax | 11 | $2,068 | $188 |
| Valacyclovir | 23 | $743 | $32 |
| Fluorometholone | 11 | $734 | $67 |
| Dorzolamide-Timolol | 21 | $352 | $17 |
| Latanoprost | 30 | $343 | $11 |
| Ketorolac Tromethamine | 15 | $284 | $19 |
| Brimonidine | 25 | $274 | $11 |
| Acyclovir | 11 | $203 | $18 |
| Timolol Maleate | 22 | $170 | $8 |
| Prednisone | 25 | $165 | $7 |
| Ranitidine | 12 | $49 | $4 |
2015: 1 drug
| Prednisolone Acetate | 19 | $1,416 | $75 |
2014: 12 drugs
| Prednisolone Acetate | 68 | $4,417 | $65 |
| Doxycycline Hyclate | 25 | $3,100 | $124 |
| Prolensa | 16 | $2,999 | $187 |
| Lotemax | 12 | $1,749 | $146 |
| Vigamox | 14 | $1,527 | $109 |
| Dorzolamide-Timolol | 20 | $588 | $29 |
| Polymyxin B Sul-Trimethoprim | 34 | $321 | $9 |
| Ketorolac Tromethamine | 17 | $293 | $17 |
| Latanoprost | 21 | $215 | $10 |
| Acyclovir | 11 | $193 | $18 |
| Dorzolamide | 11 | $185 | $17 |
| Brimonidine | 14 | $162 | $12 |
2013: 4 drugs
| Prednisolone Acetate | 24 | $873 | $36 |
| Dorzolamide-Timolol | 19 | $764 | $40 |
| Latanoprost | 12 | $154 | $13 |
| Polymyxin B Sul-Trimethoprim | 13 | $140 | $11 |
Money from drug and device companies
$294 in 2023
| 2023 | 1 | 1 | None | $294 |
| 2021 | 1 | 1 | None | $25 |
| 2019 | 2 | 3 | None | $168 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Carl Zeiss Meditec USA | Cirrus 5000 With Angioplex | $294 | 1 payment
|
See the published payment
| Carl Zeiss Meditec USA | Long term medical supply or device loan · 2023-06-30 | Cirrus 5000 With Angioplex | $294 |
See earlier years (2021, 2019)
2021: $25
| Sight Sciences | Omni(R) Surgical System (US) | $25 | 1 payment
|
2019: $168
| Dompe US | Oxervate | $114 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Symfony Toric Iol | $54 | 2 payments
|
Professional record
- NPI
- 1891947925
- Licence
- CA C150277California C150277: Current · expires 2027-05-31
- Trained
- Emory University School of Medicine, 2007
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2008-10-21
- NPI last updated
- 2020-03-04
- NPI record certified
- 2020-03-04
This is when the NPI record was last certified, not a medical board exam.